182 related articles for article (PubMed ID: 20564001)
1. Impaired activation-induced cell death promotes spontaneous arthritis in antigen (cartilage proteoglycan)-specific T cell receptor-transgenic mice.
Boldizsar F; Kis-Toth K; Tarjanyi O; Olasz K; Hegyi A; Mikecz K; Glant TT
Arthritis Rheum; 2010 Oct; 62(10):2984-94. PubMed ID: 20564001
[TBL] [Abstract][Full Text] [Related]
2. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
Berlo SE; Guichelaar T; Ten Brink CB; van Kooten PJ; Hauet-Broeren F; Ludanyi K; van Eden W; Broeren CP; Glant TT
Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
[TBL] [Abstract][Full Text] [Related]
3. Naive transgenic T cells expressing cartilage proteoglycan-specific TCR induce arthritis upon in vivo activation.
Berlo SE; van Kooten PJ; Ten Brink CB; Hauet-Broere F; Oosterwegel MA; Glant TT; Van Eden W; Broeren CP
J Autoimmun; 2005 Nov; 25(3):172-80. PubMed ID: 16257179
[TBL] [Abstract][Full Text] [Related]
4. T cell receptor (TCR) signal strength controls arthritis severity in proteoglycan-specific TCR transgenic mice.
Olasz K; Boldizsar F; Kis-Toth K; Tarjanyi O; Hegyi A; van Eden W; Rauch TA; Mikecz K; Glant TT
Clin Exp Immunol; 2012 Feb; 167(2):346-55. PubMed ID: 22236012
[TBL] [Abstract][Full Text] [Related]
5. Arthritogenic T cells drive the recovery of autoantibody-producing B cell homeostasis and the adoptive transfer of arthritis in SCID mice.
Kis-Toth K; Radacs M; Olasz K; van Eden W; Mikecz K; Glant TT
Int Immunol; 2012 Aug; 24(8):507-17. PubMed ID: 22518822
[TBL] [Abstract][Full Text] [Related]
6. Induction of arthritis in SCID mice by T cells specific for the "shared epitope" sequence in the G3 domain of human cartilage proteoglycan.
Hanyecz A; Bárdos T; Berlo SE; Buzás E; Nesterovitch AB; Mikecz K; Glant TT
Arthritis Rheum; 2003 Oct; 48(10):2959-73. PubMed ID: 14558103
[TBL] [Abstract][Full Text] [Related]
7. Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune murine arthritis.
Zhang J; Bárdos T; Mikecz K; Finnegan A; Glant TT
J Immunol; 2001 Apr; 166(8):4981-6. PubMed ID: 11290777
[TBL] [Abstract][Full Text] [Related]
8. Reporters of TCR signaling identify arthritogenic T cells in murine and human autoimmune arthritis.
Ashouri JF; Hsu LY; Yu S; Rychkov D; Chen Y; Cheng DA; Sirota M; Hansen E; Lattanza L; Zikherman J; Weiss A
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18517-18527. PubMed ID: 31455730
[TBL] [Abstract][Full Text] [Related]
9. The role of citrullination of an immunodominant proteoglycan (PG) aggrecan T cell epitope in BALB/c mice with PG-induced arthritis.
Misják P; Bősze S; Horváti K; Pásztói M; Pálóczi K; Holub MC; Szakács F; Aradi B; György B; Szabó TG; Nagy G; Glant TT; Mikecz K; Falus A; Buzás EI
Immunol Lett; 2013 Apr; 152(1):25-31. PubMed ID: 23578666
[TBL] [Abstract][Full Text] [Related]
10. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
Szántó S; Bárdos T; Szabó Z; David CS; Buzás EI; Mikecz K; Glant TT
Arthritis Rheum; 2004 Jun; 50(6):1984-95. PubMed ID: 15188376
[TBL] [Abstract][Full Text] [Related]
11. Cartilage proteoglycan-specific T cells as vectors of immunomodulatory biologicals in chronic proteoglycan-induced arthritis.
Guichelaar T; ten Brink CB; van Kooten PJ; Berlo SE; Lafeber FP; Broeren CP; van Eden W; Broere F
Mol Immunol; 2008 Aug; 45(13):3526-35. PubMed ID: 18579208
[TBL] [Abstract][Full Text] [Related]
12. Tissue specific CD4+ T cell priming determines the requirement for interleukin-23 in experimental arthritis.
Olalekan SA; Cao Y; Finnegan A
Arthritis Res Ther; 2014 Sep; 16(5):440. PubMed ID: 25253467
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis.
Kezic JM; Glant TT; Rosenbaum JT; Rosenzweig HL
Arthritis Res Ther; 2012 Jan; 14(1):R18. PubMed ID: 22269151
[TBL] [Abstract][Full Text] [Related]
14. Autoantigen-specific IL-10-transduced T cells suppress chronic arthritis by promoting the endogenous regulatory IL-10 response.
Guichelaar T; ten Brink CB; van Kooten PJ; Berlo SE; Broeren CP; van Eden W; Broere F
J Immunol; 2008 Feb; 180(3):1373-81. PubMed ID: 18209031
[TBL] [Abstract][Full Text] [Related]
15. Proteoglycan aggrecan conducting T cell activation and apoptosis in a murine model of rheumatoid arthritis.
Hanyecz A; Olasz K; Tarjanyi O; Nemeth P; Mikecz K; Glant TT; Boldizsar F
Biomed Res Int; 2014; 2014():942148. PubMed ID: 24605340
[TBL] [Abstract][Full Text] [Related]
16. Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.
Markovics A; Ocskó T; Katz RS; Buzás EI; Glant TT; Mikecz K
PLoS One; 2016; 11(7):e0160284. PubMed ID: 27466816
[TBL] [Abstract][Full Text] [Related]
17. Oral or nasal antigen induces regulatory T cells that suppress arthritis and proliferation of arthritogenic T cells in joint draining lymph nodes.
Broere F; Wieten L; Klein Koerkamp EI; van Roon JA; Guichelaar T; Lafeber FP; van Eden W
J Immunol; 2008 Jul; 181(2):899-906. PubMed ID: 18606641
[TBL] [Abstract][Full Text] [Related]
18. Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints.
Angyal A; Egelston C; Kobezda T; Olasz K; László A; Glant TT; Mikecz K
Arthritis Res Ther; 2010; 12(2):R44. PubMed ID: 20298547
[TBL] [Abstract][Full Text] [Related]
19. Altered peptide ligands inhibit arthritis induced by glucose-6-phosphate isomerase peptide.
Iwanami K; Matsumoto I; Yoshiga Y; Inoue A; Kondo Y; Yamamoto K; Tanaka Y; Minami R; Hayashi T; Goto D; Ito S; Nishimura Y; Sumida T
Arthritis Res Ther; 2009; 11(6):R167. PubMed ID: 19900268
[TBL] [Abstract][Full Text] [Related]
20. Molecular manipulation with the arthritogenic epitopes of the G1 domain of human cartilage proteoglycan aggrecan.
Murad YM; Szabó Z; Ludányi K; Glant TT
Clin Exp Immunol; 2005 Nov; 142(2):303-11. PubMed ID: 16232217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
